Appendix B.2 Data Reporting Instructions for Food Contract Audits
ORA FIELD MANAGEMENT DIRECTIVE No. 76
Appendix B.2
State Contracts-Evaluation of Inspectional Performance
State Program Management
1/23/14 Revised
Printer Friendly Version: PDF Size 37kb
Audits of contract inspections are reported as investigation operations, operation code 13. The PAC for food contract audits is 03R843
- Select Investigation Operation
- Select Stand Alone Investigation
- At the Maintain Investigations screen, data must be entered in the fields listed here.
- Accomplishing District
- Start Date
- Investigation Basis – select Surveillance
- PAC – select 03R843
- Reason for Investigation – enter the applicable descriptions listed here:
For general food sanitation inspections:
Food Sanitation Contract Audit
Food Sanitation Training Audit
Food Sanitation Verification AuditFor LACF or acidified food inspections:
LACF Contract Audit
LACF Training Audit
LACF Verification AuditFor seafood HACCP inspections:
Seafood HACCP Contract Audit
Seafood HACCP Training Audit
Seafood HACCP Verification AuditFor juice HACCP inspections:
Juice HACCP Contract Audit
Juice HACCP Training Audit
Juice HACCP Verification Audit
NOTE: The instructions above do not apply to joint inspections conducted for purposes other than auditing a contract inspection. Joint inspections conducted for purposes other than auditing, such as compliance/enforcement and training should continue to be reported as an inspection under operation code 12, and against the appropriate PAC and compliance program. Only one coversheet should be prepared per inspection with both FDA and state time recorded for joint inspection purposes.
Reporting Instructions for States in Phase II and III
Only the State inspector, not the State auditor, will report his/her time in eSAF. The number of hours will be reported as an audit not an inspection. At the time data is entered into eSAF, the State data entry user will change the Inspection Type field on the Add/Update Inspection Operation screen from "State" to "Audit". In Phase II, the FDA investigator will report time following the instructions in the Appendix B.2